Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
All >

News > Financings

Find below news about investments, credits, grants in Germany, Austria and Switzerland or including organisations from these countries.

Total search results: 4178 | Ordered by Date (descending)
1 2 3 ... 40 41 42  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Cerenis Therapeutics S.A.. (4/17/19). "Press Release: Cerenis Therapeutics Has Decided to Terminate the Proposed Merger with H4Orphan Pharma". Toulouse. 2019-04-17
Kiadis Pharma N.V.. (4/17/19). "Press Release: Kiadis to Acquire CytoSen Therapeutics, Inc.". Amsterdam. 2019-04-17
Hookipa Pharma Inc.. (4/17/19). "Press Release: Hookipa Pharma Announces Pricing of Initial Public Offering". New York, NY & Vienna. 2019-04-17
Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne. 2019-04-16
Catalent, Inc.. (4/15/19). "Press Release: Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion". Somerset, NJ & Baltimore, MD. 2019-04-15
Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2019-04-09
Gesynta Pharma AB. (4/4/19). "Press Release: Gesynta Pharma Secures 6 MEUR for Development Programs in Financing Round Led by Industrifonden". Solna. 2019-04-04
Dyne Therapeutics. (4/3/19). "Press Release: Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases". Cambridge, MA. 2019-04-03
Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. 2019-04-03
Bruker Corporation. (4/3/19). "Press Release: Bruker Announces Acquisition of Rave LLC". Billerica, MA. 2019-04-03
AgomAb Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent. 2019-04-03
Bayer AG. (4/2/19). "Press Release: Leaps by Bayer and Khloris Join Forces to Develop Induced Pluripotent Stem Cells (iPSCs) as Breakthrough Anti-cancer Vaccines". Leverkusen & South San Francisco, CA. 2019-04-02
Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. 2019-04-01
Novartis AG. (4/1/19). "Press Release: AveXis Expands World-leading Gene Therapy Manufacturing Capacity with Purchase of Advanced Biologics Therapy Manufacturing Campus in Longmont, Colorado". Basel. 2019-04-01
Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. 2019-04-01
Cell Mogrify Ltd.. (4/1/19). "Press Release: Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic". Cambridge. 2019-04-01
Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA. 2019-04-01
Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. 2019-03-28
Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. 2019-03-28
Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. 2019-03-27
Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. 2019-03-27
Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". 2019-03-26
Evotec AG. (3/26/19). "Press Release: Evotec and The Mark Foundation for Cancer Research Announce Strategic Collaboration in Immuno-oncology". Hamburg. 2019-03-26
Synerkine Pharma B.V.. (3/25/19). "Press Release: Synerkine Pharma Raises EUR3.3 Million in Series A Financing". Utrecht. 2019-03-25
Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA. 2019-03-24
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
Cell Mogrify Ltd.. (3/18/19). "Press Release: Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies". Cambridge. 2019-03-18
Karuna Therapeutics, Inc.. (3/18/19). "Press Release: Karuna Announces $68 Million Series B Financing". Boston, MA. 2019-03-18
Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. 2019-03-14
CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. 2019-03-14
Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. 2019-03-14
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. 2019-03-12
Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. 2019-03-11
Gilde Healthcare Partners. (3/7/19). "Press Release: Gilde Healthcare Raises €200 Million for New Private Equity Fund. Targeting Lower Mid-market Healthcare Investments in the Benelux and DACH Regions". Utrecht & Frankfurt a. M.. 2019-03-07
SOM Biotech S.L.. (3/7/19). "Press Release: SOM Biotech Closes a Financing Round of 7m Euros". Barcelona. 2019-03-07
Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. 2019-03-05
Merck KGaA. (3/5/19). "Press Release: Open Letter to Versum Shareholders from Merck". Darmstadt. 2019-03-05
Algenex S.L.. (3/5/19). "Press Release: Algenex Closes Funding Round and Strengthens Team with Key Senior Manager Appointments". Madrid. 2019-03-05
NovoGo Therapeutics AG. (3/4/19). "Press Release: NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke". Zurich. 2019-03-04
Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma A/S Announces Proposed Public Offering of ADSs". Copenhagen. 2019-03-04
Nightstar Therapeutics plc. (3/4/19). "Press Release: Nightstar Therapeutics plc Reaches Agreement to Be Acquired by Biogen". 2019-03-04
Aimmune Therapeutics, Inc.. (2/28/19). "Press Release: Aimmune Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Operational Highlights". Brisbane, CA. 2019-02-28
MeiraGTx Holdings plc. (2/27/19). "Press Release: MeiraGTx Announces $80 Million Private Placement of Ordinary Shares". London & New York, NY. 2019-02-27
Merck KGaA. (2/27/19). "Press Release: Merck Submits All-Cash Proposal to Acquire Versum. $48 Per Share Proposal Represents a Premium to Current Value of Entegris’ All-Stock Proposal". Darmstadt. 2019-02-27
Genfit S.A.. (2/27/19). "Press Release: Genfit Files Registration Statement for Proposed Initial Public Offering in the United States". Lille & Cambridge, MA. 2019-02-27
Samsara Therapeutics, Inc.. (2/26/19). "Press Release: Samsara Therapeutics Closes Seed Round Led by Apollo Ventures". New York, NY & Hamburg. 2019-02-26
Hookipa Pharma Inc.. (2/26/19). "Press Release: Hookipa Pharma Raises $37.4 Million (€33.2 Million) in Series D Financing". New York, NY & Vienna. 2019-02-26
Syncona Ltd.. (2/26/19). "Press Release: Syncona Leads CHF 35 Million Series A Financing in Anaveon, a New Immuno-oncology Company". 2019-02-26
Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC. 2019-02-25
Roche. (2/25/19). "Press Release: Roche Enters into Definitive Merger Agreement to Acquire Spark Therapeutics". Basel. 2019-02-25
Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. 2019-02-21
BiomX Ltd.. (2/20/19). "Press Release: BiomX Raises $32 Million in Series B Financing. Proceeds Will Be Used Primarily to Advance Leading IBD and Acne Programs to the Clinic". Ness Ziona. 2019-02-20
Cell Mogrify Ltd.. (2/20/19). "Press Release: Mogrify Raises $3.7 Million USD Seed Funding to Accelerate its Mission to Transform Cell Therapy via Direct Cellular Conversion". Cambridge. 2019-02-20
Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam. 2019-02-20
Aidence B.V.. (2/20/19). "Press Release: Aidence Raises €10 Million Series A to Revolutionise the Medical Imaging Industry". 2019-02-20
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen. 2019-02-20
GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi 2019-02-19
S-Biomedic N.V.. (2/18/19). "Press Release: Microbiome Pioneer S-Biomedic Completes Series A Round with DSM Venturing". Belgium. 2019-02-18
Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. 2019-02-15
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. 2019-02-14
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Eurofins. (2/11/19). "Press Release: New Site for Microbiology and DNA Analysis in Bremerhaven. Q-Bioanalytic Strengthens the Eurofins Laboratory Network". 2019-02-11
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. 2019-02-07
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". 2019-01-31
Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. 2019-01-30
Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN. 2019-01-30
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". 2019-01-29
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". 2019-01-29
Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". 2019-01-23
Pharnext S.A.. (1/23/19). "Press Release: Pharnext Raises €15 Million without Discount". Paris. 2019-01-23
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Successfully Raises EUR 55.50 Milion in an Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. 2019-01-23
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Upsizes Its Equity Placement Due to Significant Demand [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. 2019-01-23
Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Launches Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. 2019-01-23
BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. 2019-01-23
Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. 2019-01-22
Scailyte AG. (1/22/19). "Press Release: Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures and Zürcher Kantonalbank as Investors". 2019-01-22
GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2019-01-22
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna. 2019-01-21
Miltenyi Biotec GmbH. (1/17/19). "Press Release: Miltenyi Biotec Acquires Promising Non-harmful Imaging Process". Bergisch Gladbach. 2019-01-17
Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. 2019-01-16
High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". 2019-01-16
Minoryx Therapeutics S.L.. (1/15/19). "Press Release: Minoryx Therapeutics Extends Its Activities in Belgium". Mataró, Barcelona & Charleroi. 2019-01-15
InterAx Biotech AG. (1/15/19). "Press Release: InterAx Biotech Closes Financing Round of CHF 3 Million and Appoints New Member of the Board". 2019-01-15
Life Biosciences LLC. (1/15/19). "Press Release: Life Biosciences Announces Closing of $50 Million Series B Financing Round". Boston, MA. 2019-01-15
Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement". 2019-01-14
Life Biosciences LLC. (1/9/19). "Press Release: Senolytic Therapeutics Kicks Off Q1 2019 with High-profile Speaking Events Featuring Co-founders Marc Ramis and Manuel Serrano". Boston, MA. 2019-01-09
Curetis N.V.. (1/8/19). "Press Release: Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test". Vienna, Amsterdam & Holzgerlingen. 2019-01-08
Galapagos N.V.. (1/8/19). "Press Release: Sands Capital Reports 5.7% Holding in Galapagos". Mechelen. 2019-01-08
GreenLight Biosciences, Inc.. (1/8/19). "Press Release: GreenLight Biosciences Announces $50 Million Funding Round". Medford, MA. 2019-01-08
1 2 3 ... 40 41 42  next pagenext page



Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top